[go: up one dir, main page]

ES2142817T3 - Compuestos triciclicos como antagonistas de la angiotensina ii. - Google Patents

Compuestos triciclicos como antagonistas de la angiotensina ii.

Info

Publication number
ES2142817T3
ES2142817T3 ES92311777T ES92311777T ES2142817T3 ES 2142817 T3 ES2142817 T3 ES 2142817T3 ES 92311777 T ES92311777 T ES 92311777T ES 92311777 T ES92311777 T ES 92311777T ES 2142817 T3 ES2142817 T3 ES 2142817T3
Authority
ES
Spain
Prior art keywords
alkyl
represent
hydrogen
fenil
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92311777T
Other languages
English (en)
Inventor
Etsuo Ohshima
Fumihiko Kanai
Hideyuki Sato
Hiroyuki Obase
Toshiaki Kumazawa
Shiho Takahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of ES2142817T3 publication Critical patent/ES2142817T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PRESENTAN NUEVOS COMPUESTOS TRICICLICOS Y SALES DE LOS MISMOS QUE SON UTILES COMO ANTAGONISTAS RECEPTORES DE LA AII. ESTOS SON LOS COMPUESTOS DE LA FORMULA I Y SUS SALES: R1 REPRESENTA HIDROGENO, HALOGENO O ALQUIL C1-C6; A REPRESENTA CIANO, CARBOXIL, TETRAZOLIL, FENIL SUSTITUIDO CON CIANO, FENIL SUSTITUIDO CON CARBOXIL O FENIL SUSTITUIDO CON TETRAZOLIL; C REPRESENTA -(CH2)M-, EN DONDE M ES 0, 1 O 2; W REPRESENTA UN GRUPO DE LA FORMULA EN DONDE (ALFA) ES: EN DONDE R2, R3 Y R4 SON CADA UNA HIDROGENO, HALOGENO, ALQUIL C1C6, CICLOALQUIL C2-C6, ALQUIL C1-C6 HALOGENADO, HIDROXIDO, ALCOXIDO C1-C6, AMINO, ALQUILAMINO C1-C6, CARBOXIL O ALCOXICARBONIL C1-C6; Y Q1-Q2-Q3-Q4 REPRESENTAN N=CH-CH=CH, CH=CH-CH=CH O CH2-CH2-CH2-CH2; (BETA) ES: EN DONDE R2, R3 Y R4 SON CADA UNA COMO SE DEFINIERON ANTERIORMENTE GAMMA ES EN DONDE R5 Y R6 REPRESENTAN CADA UNA HIDROGENO, ALQUIL C1-C6 O CICLOALQUIL C3-C5, Y R7 REPRESENTA CARBOXIL, ALCOXICARBONIL C1C6, CARBAMOIL O HIDROXIMETIL; Y (DELTA) ES: EN DONDE R8 Y R9 REPRESENTAN CADA UNA HIDROGENO O ALQUIL C1-C6, Y Q REPRESENTA N O CH; X1-X2-X3 REPRESENTAN UN GRUPO CH=CH, CH-CH2, CH-CH(COOH)
ES92311777T 1991-12-27 1992-12-24 Compuestos triciclicos como antagonistas de la angiotensina ii. Expired - Lifetime ES2142817T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34729491 1991-12-27

Publications (1)

Publication Number Publication Date
ES2142817T3 true ES2142817T3 (es) 2000-05-01

Family

ID=18389240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92311777T Expired - Lifetime ES2142817T3 (es) 1991-12-27 1992-12-24 Compuestos triciclicos como antagonistas de la angiotensina ii.

Country Status (4)

Country Link
EP (1) EP0549352B1 (es)
AT (1) ATE190058T1 (es)
DE (1) DE69230721T2 (es)
ES (1) ES2142817T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716196B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.
CA2361734A1 (en) * 1999-01-26 2000-10-12 Andre Rosowsky Pharmaceutically active compounds and methods of use thereof
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
JPWO2004017994A1 (ja) * 2002-08-22 2005-12-08 協和醗酵工業株式会社 喘息の予防および／または治療剤
AU2003262230A1 (en) * 2002-08-22 2004-03-11 Kyowa Hakko Kogyo Co., Ltd. Preventive and/or therapeutic drugs for itch
EP1988091B1 (en) * 2007-02-07 2015-06-10 Kyowa Hakko Kirin Co., Ltd. Tricyclic compounds
EP3081213B1 (en) * 2008-08-06 2020-04-01 Kyowa Kirin Co., Ltd. Tricyclic compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
DE122010000024I1 (de) * 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen

Also Published As

Publication number Publication date
ATE190058T1 (de) 2000-03-15
DE69230721D1 (de) 2000-04-06
EP0549352B1 (en) 2000-03-01
EP0549352A2 (en) 1993-06-30
DE69230721T2 (de) 2000-08-31
EP0549352A3 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
ES2063153T3 (es) Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2062974T3 (es) Compuestos de cefalosporina, procedimientos para su preparacion y agentes antibacterianos.
ES2161231T3 (es) Compuestos heterociclicos como antagonistas de bradiquinina.
AR240929A2 (es) "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas"
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
CO4340623A1 (es) Derivados de indolina, metodo de preparacion y uso
AR247389A1 (es) Derivados de 2,4-diamino-5-ciano-pirimidinas, excluidos sus usos terapeuticos, procedimiento para su preparacion, intermediarios y composiciones que las contienen como antiparasitarios
ES2064771T3 (es) Antagonistas de los receptores muscarinicos.
ES476901A1 (es) Un procedimiento para la preparacion de nuevos derivados de somatostatina.
AR245494A1 (es) Una composicion detergente.
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
ES2104794T3 (es) 3-isoxazolilfenil-compuestos, su obtencion y su empleo.
AR246962A1 (es) Procedimiento para preparar derivados alquilamino-alquilenicos de ciertos 2h-1-benzopiranos.
ES2142817T3 (es) Compuestos triciclicos como antagonistas de la angiotensina ii.
DK429089D0 (da) Alkylbenzylaminer
ES2108595B1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
ES2141763T3 (es) Fenilcarbonatos y fenilureas sustituidos, su preparacion y su uso como antagonistas de 5-ht4.
MX9207594A (es) Compuestos de tiazolidina que contienen un grupo de quinona, su preparacion y sus usos terapeuticos.
ES2063381T3 (es) Antagonistas de los receptores muscarinicos.
AR006189A1 (es) Aminoalquil-eteres y acilaminoalquil-eteres, procedimiento para su preparacion y su utilizacion como antagonistas de receptores de bradiquinina
DK448684A (da) Alkyldiaminderivater og deres anvendelse som laegemidler
ES2071479T3 (es) Derivados de indano.
ES2074047T3 (es) Compuestos de benzoilo fluorados.
AR241534A1 (es) Compuestos de 7-(2-(5-amino-1,2,4-tiazol-3-il)-2-alcoxiimino-acetamido)-3-metil-imidazo piridinio o imidazo-pirimidinio-3-cefem-4-carboxilato y sus sales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 549352

Country of ref document: ES